Institute For Gynecologic Oncology Inc is categorized under Oncologists in Atlanta, GA and active since 1988.
Institute For Gynecologic Oncology Inc was established in 1988, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Benedict Benigno at the company’s headquarters by writing to 980 Johnson Fy Road Ne, Atlanta, Georgia GA 30342 or by phoning (404) 252-1293. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Gynecologic Oncology Inc |
| Contact Person: | Benedict Benigno |
| Address: | 980 Johnson Fy Road Ne, Atlanta, Georgia 30342 |
| Phone Number: | (404) 252-1293 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1988 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Institute For Gynecologic Oncology Inc was started in 1988 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Benedict Benigno for inquiries that concern Institute For Gynecologic Oncology Inc by calling the company number (404) 252-1293, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Institute For Gynecologic Oncology Inc can be found at the coordinates 33.857207,-84.298233 as well as the street address 980 Johnson Fy Road Ne in Atlanta, Georgia 30342.
For its online presence, you may visit Institute For Gynecologic Oncology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.